Where Are Biotech ETFs Headed After Q4 Earnings?
https://www.zacks.com/stock/news/2226390/where-are-biotech-etfs-headed-after-q4-earnings?cid=CS-ZC-FT-etf_news_and_commentary-2226390
Feb 14, 2024 - Look into how Biotech ETFs performed after Q4 earnings.
0
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
https://www.fool.com/investing/2024/04/05/got-5000-these-3-high-yielding-dividend-stocks-are/?source=iedfolrf0000001
Apr 05, 2024 - All of these stocks pay generous dividends that income investors will appreciate.
0
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
https://www.zacks.com/stock/news/2263449/gilead-gild-q1-loss-narrower-than-expected-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2263449
Apr 26, 2024 - Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
0
Top Research Reports for Merck, ServiceNow & Blackstone
https://www.zacks.com/commentary/2228528/top-research-reports-for-merck-servicenow-blackstone?cid=CS-ZC-FT-research_daily-2228528
Feb 20, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), ServiceNow, Inc. (NOW) and Blackstone Inc. (BX).
0
The AI Race Gets Litigious
https://www.fool.com/investing/2024/03/09/the-ai-race-gets-litigious/?source=iedfolrf0000001
Mar 09, 2024 - We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
0
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2262804/gilead-gild-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2262804
Apr 25, 2024 - Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2262696/gilead-sciences-gild-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2262696
Apr 25, 2024 - Gilead (GILD) delivered earnings and revenue surprises of 11.41% and 5.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/04/25/gilead-sciences-gild-q1-2024-earnings-call-transcr/?source=iedfolrf0000001
Apr 25, 2024 - GILD earnings call for the period ending March 31, 2024.
0
Pages: 1
Page 1